Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Epsin-like pseudogene (ENSG00000266105/LOC100287539) is a segment of DNA in the human genome that resembles the gene for epsin or an epsin-related protein but is incapable of producing a functional protein product[1][2]. Classified as a pseudogene, it is a nonfunctional remnant that may have arisen from gene duplication or retrotransposition, and typically lacks the necessary regulatory elements to enable gene expression[3]. While pseudogenes, in rare cases, can influence cellular function through regulatory RNA mechanisms, there is no evidence that this specific epsin-like pseudogene acts as a molecular target, biomarker, or is involved in disease mechanisms[4]. It is not indicated as a receptor, enzyme, transporter, transcription factor, or any functional molecular class relevant to pharmacology or therapeutics. Pseudogenes may be transcribed at low levels or may affect genetic studies due to sequence similarities with functional genes, but they do not display protein-level activity, interact with drugs, or pose known therapeutic safety concerns[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Epsin-like pseudogene.